Abstract
DNA methylation is an important epigenetic modification of DNA sequences, which could potentially affect gene expression and final phenotypes. Abnormal methylation has been discovered in many types of cancers and other human diseases. Detecting differentially methylated loci (DML) and differentially methylated regions (DMRs) is critical in understanding the genetic mechanism of cancer and identifying biomarkers and treatment targets, which could be used for cancer diagnosis, prognosis, prevention, and treatment. Next-generation sequencing (NGS) has been widely used to generate genome-wide methylation data. These data provide unique challenges in the differential methylation analysis at genomic levels. In this paper, we discuss these challenges and some statistical and computational approaches for detecting DML and DMRs for NGS methylation data.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Maher B. Personal genomes: the case of the missing heritability. Nat News. 2008;456:18–21. doi:10.1038/456018a.
Eichler EE, Flint J, Gibson G, et al. Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet. 2010;11:446–50. doi:10.1038/nrg2809.
Handel AE, Ebers GC, Ramagopalan SV. Epigenetics: molecular mechanisms and implications for disease. Trends Mol Med. 2010;16:7–16. doi:10.1016/j.molmed.2009.11.003.
Egger G, Liang G, Aparicio A, Jones PA. Epigenetics in human disease and prospects for epigenetic therapy. Nature. 2004;429:457–63. doi:10.1038/nature02625.
Robertson KD. DNA methylation and human disease. Nat Rev Genet. 2005;6:597–610. doi:10.1038/nrg1655.
Ferguson-Smith AC, Surani MA. Imprinting and the epigenetic asymmetry between parental genomes. Science. 2001;293:1086–9. doi:10.1126/science.1064020.
Lee JT. Molecular links between X-inactivation and autosomal imprinting: X-inactivation as a driving force for the evolution of imprinting? Curr Biol. 2003;13:R242–54. doi:10.1016/S0960-9822(03)00162-3.
Ehrlich M, Gama-Sosa MA, Huang L-H, et al. Amount and distribution of 5-methylcytosine in human DNA from different types of tissues or cells. Nucleic Acids Res. 1982;10:2709–21. doi:10.1093/nar/10.8.2709.
Esteller M, Herman JG. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol. 2002;196:1–7. doi:10.1002/path.1024.
Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer. 2004;4:143–53. doi:10.1038/nrc1279.
Bird AP. CpG-rich islands and the function of DNA methylation. Nature. 1986;321:209–13. doi:10.1038/321209a0.
Issa J-P. CpG island methylator phenotype in cancer. Nat Rev Cancer. 2004;4:988–93. doi:10.1038/nrc1507.
Müller HM, Oberwalder M, Fiegl H, et al. Methylation changes in faecal DNA: a marker for colorectal cancer screening? The Lancet. 2004;363:1283–5. doi:10.1016/S0140-6736(04)16002-9.
Nakamura N, Takenaga K. Hypomethylation of the metastasis-associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines. Clin Exp Metastasis. 1998;16:471–9. doi:10.1023/A:1006589626307.
Zilberman D, Henikoff S. Genome-wide analysis of DNA methylation patterns. Development. 2007;134:3959–65. doi:10.1242/dev.001131.
Yan PS, Shi H, Rahmatpanah F, et al. Differential distribution of DNA methylation within the RASSF1A CpG island in breast cancer. Cancer Res. 2003;63:6178–86.
Vucetic Z, Kimmel J, Totoki K, et al. Maternal high-fat diet alters methylation and gene expression of dopamine and opioid-related genes. Endocrinology. 2010;151:4756–64. doi:10.1210/en.2010-0505.
Xu H, Podolsky RH, Ryu D, et al. A method to detect differentially methylated loci with next-generation sequencing. Genet Epidemiol. 2013;37:377–82. doi:10.1002/gepi.21726.
Rao JNK, Scott AJ. A simple method for the analysis of clustered binary data. Biometrics. 1992;48:577–85. doi:10.2307/2532311.
Akalin A, Garrett-Bakelman FE, Kormaksson M, et al. Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia. PLoS Genet. 2012;8:e1002781. doi:10.1371/journal.pgen.1002781.
Bediaga NG, Acha-Sagredo A, Guerra I, et al. DNA methylation epigenotypes in breast cancer molecular subtypes. Breast Cancer Res BCR. 2010;12:R77. doi:10.1186/bcr2721.
Yang Y, Nephew K, Kim S. A novel k-mer mixture logistic regression for methylation susceptibility modeling of CpG dinucleotides in human gene promoters. BMC Bioinformatics. 2012;13 Suppl 3:S15. doi:10.1186/1471-2105-13-S3-S15.
Akalin A, Kormaksson M, Li S, et al. methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles. Genome Biol. 2012;13:R87. doi:10.1186/gb-2012-13-10-r87.
Spyrou C, Stark R, Lynch AG, Tavaré S. BayesPeak: Bayesian analysis of ChIP-seq data. BMC Bioinformatics. 2009;10:299. doi:10.1186/1471-2105-10-299.
Zheng S, Chen L. A hierarchical Bayesian model for comparing transcriptomes at the individual transcript isoform level. Nucleic Acids Res. 2009;37:e75. doi:10.1093/nar/gkp282.
Wu G, Yi N, Absher D, Zhi D. Statistical quantification of methylation levels by next-generation sequencing. PLoS One. 2011;6:e21034. doi:10.1371/journal.pone.0021034.
Down TA, Rakyan VK, Turner DJ, et al. A Bayesian deconvolution strategy for immunoprecipitation-based DNA methylome analysis. Nat Biotechnol. 2008;26:779–85. doi:10.1038/nbt1414.
Hardcastle TJ, Kelly KA. baySeq: empirical Bayesian methods for identifying differential expression in sequence count data. BMC Bioinformatics. 2010;11:422. doi:10.1186/1471-2105-11-422.
Hardcastle TJ, Kelly KA. Empirical Bayesian analysis of paired high-throughput sequencing data with a beta-binomial distribution. BMC Bioinformatics. 2013;14:135. doi:10.1186/1471-2105-14-135.
Kruschke JK. What to believe: Bayesian methods for data analysis. Trends Cogn Sci. 2010;14:293–300. doi:10.1016/j.tics.2010.05.001.
Chen Z, Liu Q, Nadarajah S. A new statistical approach to detecting differentially methylated loci for case control Illumina array methylation data. Bioinformatics. 2012;28:1109–13. doi:10.1093/bioinformatics/bts093.
Huang H, Chen Z, Huang X. Age-adjusted nonparametric detection of differential DNA methylation with case-control designs. BMC Bioinformatics. 2013;14:86. doi:10.1186/1471-2105-14-86.
Neuhäuser M. One-sided nonparametric tests for ordinal data. Percept Mot Skills. 2005;101:510–4.
Wang D, Yan L, Hu Q, et al. IMA: an R package for high-throughput analysis of Illumina’s 450K Infinium methylation data. Bioinformatics. 2012;28:729–30. doi:10.1093/bioinformatics/bts013.
Choufani S, Shapiro JS, Susiarjo M, et al. A novel approach identifies new differentially methylated regions (DMRs) associated with imprinted genes. Genome Res. 2011;21:465–76. doi:10.1101/gr.111922.110.
Pei L, Choi J-H, Liu J, et al. Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia. Epigenetics Off J DNA Methylation Soc. 2012;7:567–78. doi:10.4161/epi.20237.
Lister R, Pelizzola M, Dowen RH, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature. 2009;462:315–22. doi:10.1038/nature08514.
Pelizzola M, Ecker JR. The DNA methylome. FEBS Lett. 2011;585:1994–2000. doi:10.1016/j.febslet.2010.10.061.
Jaffe AE, Feinberg AP, Irizarry RA, Leek JT. Significance analysis and statistical dissection of variably methylated regions. Biostatistics. 2012;13:166–78. doi:10.1093/biostatistics/kxr013.
Zhang Y, Liu H, Lv J, et al. QDMR: a quantitative method for identification of differentially methylated regions by entropy. Nucleic Acids Res. 2011;39:e58. doi:10.1093/nar/gkr053.
Hansen KD, Langmead B, Irizarry RA. BSmooth: from whole genome bisulfite sequencing reads to differentially methylated regions. Genome Biol. 2012;13:R83. doi:10.1186/gb-2012-13-10-r83.
Jaffe AE, Murakami P, Lee H, et al. Bump hunting to identify differentially methylated regions in epigenetic epidemiology studies. Int J Epidemiol. 2012;41:200–9. doi:10.1093/ije/dyr238.
Hebestreit K, Dugas M, Klein H-U. Detection of significantly differentially methylated regions in targeted bisulfite sequencing data. Bioinformatics. 2013;29:1647–53. doi:10.1093/bioinformatics/btt263.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Xu, H. (2015). Differential Methylation Analysis with Next-Generation Sequencing. In: Wu, W., Choudhry, H. (eds) Next Generation Sequencing in Cancer Research, Volume 2. Springer, Cham. https://doi.org/10.1007/978-3-319-15811-2_14
Download citation
DOI: https://doi.org/10.1007/978-3-319-15811-2_14
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-15810-5
Online ISBN: 978-3-319-15811-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)